Nipro Europe Standardizes Multi-Site Pharma Workflows with Digital Automation
Nipro Europe, managing 26 sites globally, faced major inefficiencies from manual and inconsistent processes across its pharmaceutical and medical device operations. By migrating to Microsoft 365, SharePoint Online, and adopting no-code automation through FlowForma Process Automation, Nipro standardized complex, multi-step quality, marketing, and document management workflows. This approach empowered business users to develop and maintain regulatory-compliant workflows independently, reduced manual communications, enhanced audit trails, and accelerated digital transformation across all sites.
- Organization
- Nipro Europe
- Industry
- Pharma
- Location
- Belgium
- Published
- June 2024
Why do we believe this deployment?Customer identity, provider attribution, maturity, and source checks
- Customer
- Nipro Europe
- Provider
- Microsoft
- Maturity
- Unknown
- Linked source
- FlowForma
No explicit deployment-stage evidence found.
Primary read
Use case focus
Showing 3 of 3
- 1No-code workflow automation for quality control and regulatory approvals
- 2Digital marketing asset approval flows across multiple sites
- 3Document management transformation in pharma
- Migrated core processes to Microsoft 365 and SharePoint Online.
- Adopted FlowForma Process Automation to enable no-code, multi-step workflow creation by business users.
- Built dashboard for real-time status and visibility into workflow steps and sign-offs.
- Reduced manual emails, standardized document-centric processes, and enabled local site adoption.
Architecture
Key processes are digitized with Microsoft 365/SharePoint Online as the central platform. FlowForma Process Automation provides a no-code layer, allowing customized process and approval flows spanning marketing, quality, and compliance. All workflows share a unified digital audit trail and dashboard.
Sources & evidence1
- Customer explicitly identified
- Primary source available
- Technical implementation details available
- Recent evidence check available
- Last evidence check: Jun 1, 2026.
The case's original source is still reachable.
- Cited source last checked Jun 1, 2026 — ok (0/1 broken).
Measures whether this deployment's public evidence persists — not whether the system is still in production.
AI-generated summary. Verify important details with the linked sources before relying on this case.
Explore related AI use cases
Was this useful?
Community
Comments
No published comments yet.